Substantial envelope-specific CD8 T-cell immunity fails to control SIV disease

Area of Science:

• Immunology
• Vaccinology
• Virology

Background:

• Generating effective CD8 T-cell immunity against HIV is crucial for vaccine development.
• Identifying optimal viral protein targets for vaccination remains a challenge.

Purpose of the Study:

• To evaluate the efficacy of targeting Simian Immunodeficiency Virus (SIV) Env proteins versus Gag proteins for inducing CD8 T-cell responses in macaques.
• To determine if SIV Env-specific CD8 T-cell responses control viral replication and disease progression.

Main Methods:

• Pigtail macaques infected with SIV(mac251) were immunized with Gag peptides or a peptide cocktail including SIV Env.
• CD8 T-cell responses were measured, and novel Env-specific epitopes were mapped.
• Viral replication and disease markers were monitored in vaccinated and control groups.

Main Results:

• High-level SIV Env-specific CD8 T-cell responses were generated, with 7 novel epitopes identified.
• Env-specific CD8 T-cell responses were less effective than Gag-specific responses in controlling SIV replication.
• Escape mutations in Env epitopes suggested immune pressure, but did not correlate with reduced viral load.

Conclusions:

• Vaccination targeting SIV Env proteins may not induce the most effective CD8 T-cell immunity for controlling SIV infection.
• Gag-specific CD8 T-cell responses appear more promising for SIV vaccine strategies.
• Further research is needed to identify optimal HIV vaccine targets for robust T-cell immunity.